Description

This 4-part project examines the National Institute for Health and
Clinical Excellence (NICE) and its operations, and the implications for
comparative effectiveness reviews in the U.S.

Part 1 entails a
non-technical overview of NICE, encompassing its governance and
organization, topic selection procedures, evidence requirements and
assessment methods, and guidance dissemination and implementation.
Part 2 provides an in-depth investigation of evidence requirements and assessment methods.

Part 3 involves an analysis of public comments on NICE submitted to the
House of Commons Health Select Committee, focusing on key stakeholder
perspectives on the appraisal process and broader NICE operations.

Part 4 examines NICE procedures and standards in the context of the
U.S. landscape, and identifies those factors or forces unique to the
U.S. marketplace, in comparison to the U.K. and other EU Member States,
where applicable.